☆ 4.6 Article

No increase in incidence or risk of recurrence of breast cancer in ospemifene-treated patients with vulvovaginal atrophy (VVA) from a 2013-2020 US real world data

MATURITAS (2021)

Get Full Text
Add to Collection

Journal

MATURITAS
Volume 152, Issue -, Pages 81

Publisher

Elsevier BV
DOI: 10.1016/j.maturitas.2021.08.044

Keywords

-

Categories

Geriatrics & Gerontology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.